, Tracking Stock Market Picks
Enter Symbol:
Davita Inc. (DVA) [hlAlert]

up 73.86 %

Davita Inc. (DVA) rated Outperform by William Blair

Posted on: Friday,  Jul 8, 2011  11:25 AM ET by William Blair

William Blair rated Outperform Davita Inc. (NYSE: DVA) on 07/08/2011, when the stock price was $44.09. Since
then, Davita Inc. has gained 73.87% as of 08/27/2015's recent price of $76.65.
If you would have followed this William Blair's recommendation on DVA, you would have gained 73.86% of your investment in 1511 days.

DaVita Inc. is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2008, the Company operated or provided administrative services to 1,449 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 112,000 patients. It also provides acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. DaVita Inc?s dialysis and related lab services business accounts for approximately 96% of its consolidated revenues. Other ancillary services and strategic initiatives businesses account for approximately 4% of its consolidated revenues and relate primarily to its core business of providing renal care services. It also provides ancillary services and strategic initiatives, such as infusion therapy services, pharmacy services, vascular access services, disease management services and special needs plans,

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2011 11:25 AM Buy
as of 12/30/2011
1 Week down  -0.88 %
1 Month down  -0.48 %
3 Months up  20.96 %
1 YTD down  -14.01 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy